Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000912057-02-021117
Filing Date
2002-05-17
Accepted
2002-05-17 12:49:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 a2079255z424b3.htm 424B3 28839
3 G350050.JPG g350050.jpg GRAPHIC 9503
  Complete submission text file 0000912057-02-021117.txt   40012
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-86624 | Film No.: 02655930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances